December 2022 – schizophrenia

Dec 31 2022

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia – Yahoo Finance

by Clinical Editor

No Comments

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia Yahoo Finance

Dec 31 2022

Uncategorized

Over-activity in brain’s specific area linked to certain Schizophrenia symptoms: Study

by Clinical Editor

No Comments

Schizophrenia is a psychotic illness which exhibits itself in three ways: negative symptoms such as lethargy, apathy and social withdrawal, positive symptoms such as hallucinations and delusions and …

Dec 31 2022

Uncategorized

Research reveals new links between brain over-activity and schizophrenia symptoms

by Clinical Editor

No Comments

New research has shown that over-activity in a specific area of the brain is linked to certain symptoms of Schizophrenia opening up possibilities for the devel …

Dec 31 2022

Uncategorized

Schizophrenia Over the Holidays

by Clinical Editor

No Comments

However, due to the insidious onset of schizophrenia in my college years, I remember painful times struggling with severe psychosis. Mental illness presents challenges different from other illnesses …

Dec 31 2022

Uncategorized

Fingerprint images may have predictor for schizophrenia: study

by Clinical Editor

No Comments

Although a maximum accuracy of 70% does not provide enough precision for a faultless diagnosis, fingerprint images may still be valuable, especially if they are combined with other sources of...

Dec 31 2022

Uncategorized

Minerva slumps ~30% as FDA refusal on schizophrenia drug intact after panel meeting

by Clinical Editor

No Comments

Minerva Neurosciences ( NASDAQ: NERV) said that following a Type A meeting held on Nov. 30, the U.S. Food and Drug Administration (FDA) confirmed that the agency’s refusal to review...

Dec 30 2022

Uncategorized

2 men with bipolar disorder and schizophrenia missing in Detroit – FOX 2 Detroit

by Clinical Editor

No Comments

2 men with bipolar disorder and schizophrenia missing in Detroit FOX 2 Detroit

Dec 30 2022

Uncategorized

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia – Yahoo Finance

by Clinical Editor

No Comments

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia Yahoo Finance

Dec 30 2022

Uncategorized